Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 1 2

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 16Gastrointestinal 8Tumor-Agnostic 4CNS 4Breast 4Thoracic 3Other solid neoplasm 3Sarcoma 2Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Gynecologic 2Endocrine 2Myeloid 1Genitourinary 1

Conditions

Solid Tumors 1Solid Tumor 1Microsatellite Unstable Colorectal Cancer 1

Interventions

Cisplatin 42Pemetrexed 31Carboplatin 28Nivolumab 21pembrolizumab 19Gemcitabine 19atezolizumab 13Etoposide 13Injections 12Ipilimumab 11Cyclophosphamide 11Radiotherapy 10Oxaliplatin 10Filgrastim 10Docetaxel 10Bevacizumab 10tislelizumab 9Vincristine 9Specimen Handling 9durvalumab 8Paclitaxel 8Capecitabine 8tremelimumab 7toripalimab 7lenvatinib 7Everolimus 7spartalizumab 6olaparib 6niraparib 6Vinorelbine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × cobimetinib × Other solid neoplasm × Clear all
NCT02060188 2025-11-06

CheckMate142

Bristol-Myers Squibb

Phase 2 Completed
385 enrolled 17 charts 2 FDA
GastrointestinalOther solid neoplasm

Microsatellite Unstable Colorectal Cancer

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting
167 enrolled
Other solid neoplasm

Solid Tumor

NCT03264066 2021-05-11

A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors

Hoffmann-La Roche

Phase 2 Completed
87 enrolled 24 charts
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡